Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 31, 2025
Accession Number:
0001193125-25-064597
Submission Type:
POS AM
CIK:
0001260990
Company Name:
Oncternal Therapeutics, Inc.
File Number:
333-204932